Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

656 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators.
Agnelli G, Prandoni P, Santamaria MG, Bagatella P, Iorio A, Bazzan M, Moia M, Guazzaloca G, Bertoldi A, Tomasi C, Scannapieco G, Ageno W; Warfarin Optimal Duration Italian Trial Investigators. Agnelli G, et al. Among authors: ageno w. N Engl J Med. 2001 Jul 19;345(3):165-9. doi: 10.1056/NEJM200107193450302. N Engl J Med. 2001. PMID: 11463010 Free article. Clinical Trial.
Treatment of venous thromboembolism.
Ageno W. Ageno W. Int J Hematol. 2002 Aug;76 Suppl 2:40-3. doi: 10.1007/BF03165084. Int J Hematol. 2002. PMID: 12430898 Review.
Extended oral anticoagulant therapy after a first episode of pulmonary embolism.
Agnelli G, Prandoni P, Becattini C, Silingardi M, Taliani MR, Miccio M, Imberti D, Poggio R, Ageno W, Pogliani E, Porro F, Zonzin P; Warfarin Optimal Duration Italian Trial Investigators. Agnelli G, et al. Among authors: ageno w. Ann Intern Med. 2003 Jul 1;139(1):19-25. doi: 10.7326/0003-4819-139-1-200307010-00008. Ann Intern Med. 2003. PMID: 12834314 Clinical Trial.
Incidence of cancer after a first episode of idiopathic venous thromboembolism treated with 3 months or 1 year of oral anticoagulation.
Taliani MR, Agnelli G, Prandoni P, Becattini C, Moia M, Bazzan M, Ageno W, Tomasi C, Guazzaloca G, Ambrosio GB, Bertoldi A, Salvi R, Poggio R, Silingardi M; Warfarin Optimal Duration Italian Trial (WODIT) Investigators. Taliani MR, et al. Among authors: ageno w. J Thromb Haemost. 2003 Aug;1(8):1730-3. doi: 10.1046/j.1538-7836.2003.00293.x. J Thromb Haemost. 2003. PMID: 12911585 Free article.
656 results